A medical device company has developed a new technology that could improve the visualization and treatment of the affected heart tissue during catheter ablations of the left atrium of the heart. They were interested in getting an overview of the market access and reimbursement regulations in the Netherlands and Belgium in order to see what their possibilities were regarding the marketing of their technology. We provided a market access and reimbursement report for our client that described the general reimbursement structures in healthcare and medical devices more specifically in both the Netherlands and Belgium. The report also described specific topics that were relevant for their technology and strategic recommendations were given with regards to the marketing of the technology.